A Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease Patients
Clinical trial NCT00998764 · TERMINATED
Trial details
- NCT number
- NCT00998764
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2012-10-01
- Enrollment
- 494
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.